Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Pot stock Canopy Growth is rolling the dough. Here's how it'll probably be spending its cash in the quarters to come.

How Will Canopy Growth Put $3.7 Billion in Cash to Work?

Canopy Growth Corp (NYSE: CGC) is further strengthening its position as one of the leading cannabis companies in the world by receiving a license to start growing cannabis at its facility in Fredericton, New Brunswick.

Canopy Growth  Receives License For New Brunswick Facility From Health Canada

Aurora Cannabis

Cronos Group

Tilray Brands

According to Wall Street, the choice is pretty simple.

Which Pot Stock -- Aurora, Canopy, Cronos, or Tilray -- Has the Most Upside?

HEXO Corp

CBD currently exists in a legal gray area, locking small entrepreneurs out of the market.

Government Crackdowns Puts Smaller CBD Vendors In Jeopardy

Canopy Growth Corp. said Monday it has received a license from Health Canada to grow cannabis at a facility in Fredericton, New Brunswick.

Canopy Growth receives licence to grow cannabis in New Brunswick

These top marijuana stocks look really expensive. But can these looks be deceiving?

Don't Laugh: Aurora Cannabis, Canopy Growth, and Tilray Could Be Big-Time Bargains

Canada's cannabis supply chain is in big trouble.

1 Figure That Guarantees a Canadian Marijuana Oversupply Is Imminent

Canada's biggest cannabis company is laser-focused on the United States.

Here's What Canopy Growth Just Said About Its Future

GW Pharmaceuticals

Legalization has long been considered a boon for the marijuana industry.

US Marijuana Industry to Flourish in 2019: Who Gains?

Canadian pot producer Canopy Growth bought another hemp-focused company, a move that could hasten its advance into the newly-legal U.S. market for the plant.

Pot Stock Canopy Growth Adds To U.S. 'Hempire' With Latest Acquisition

Canopy Growth Corp's foray into the U.S. hemp industry is speeding up with another acquisition.
 read more

Canopy Growth Announces Acquisition of AgriNextUSA, Expanding Hemp Business

Canopy Growth Corporation announced a two-year processing and extraction agreement Wednesday with HollyWeed Manufacturing & Extracts Inc., a British Columbia-based, women-led business.

Canopy Growth, HollyWeed North Cannabis Announce 2-Year Extraction Agreement

The cannabis industry faces a rare opportunity as the drug heads toward a potential rescheduling in the United States. A new Roth Capital report suggests that multistate operators (MSOs) are the most promising companies in the space.

Roth Sees Rare Opportunity For Cannabis Industry, MSOs

Canopy Growth might be bigger when it comes to market cap. But a Cowen analyst thinks Aurora Cannabis is the better marijuana stock right now.

Why 1 Top Analyst Thinks Aurora Cannabis Beats Canopy Growth As the Best Marijuana Stock on the Market

Make no mistake, this is a commodity-based farming operation at present. With a valuation above $20 billion, investor expectations remain sky-high.

Canopy Growth: Don't Bet The Farm On It

Aphria

Therapix Biosciences

Zynerba Pharmaceuticals

There is a lot of hype regarding CBD and a lack of regulatory clarity. I discuss the big issues and identify some of the better players in the space among public-traded companies.

Investing In CBD Stocks Offers Opportunity But Risks

Amazon prospered while most dot-com era companies flopped. Could one of these top marijuana stocks be a similar success story?

Aurora Cannabis, Canopy Growth, or Tilray: Which Stock Will Be the Amazon of the Marijuana Boom?

iQIYI

Snap

Snap, iQiyi, and Canopy Growth are smoking the market this year.

3 Stocks That Have Almost Doubled in 2019

Before investing in pot stocks, you'll want to know these three things.

3 Numbers That Marijuana Stock Investors Had Better Know

And it could take a long time for Canopy Growth to beat its most significant challenger - the black market.

Here's Canopy Growth's Top Rival

Molson Coors Brewing

The green rush could be in for a reality check in 2019.

The 3 Most Overhyped Marijuana Trends

Constellation Brands

Cannabis-company Canopy Growth Corp (CGC) relationship with publisher, entrepreneur and TV personality Martha Stewart dates back more than three years, company co-CEO Bruce Linton said on CNBC's "Squawk on the Street" Thursday.

Canopy Growth's Bruce Linton Talks Martha Stewart, Constellation Brands: 'Good Science Leads To Great Products'

The news has sparked countless conversations between investors and entrepreneurs about what the deal means for the legal hemp industry, especially in the absence of meaningful guidance by the United States Food and Drug Administration (FDA) about how to regulate cannabidiol (CBD).

News for Canopy Growth Stock (CGC)